Quarterly report pursuant to Section 13 or 15(d)

Unaudited Interim Condensed Consolidated Statements of Stockholders' Equity

v3.24.3
Unaudited Interim Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Restricted shares of common stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Restricted shares of common stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2022     71,660,617        
Beginning Balance at Dec. 31, 2022 $ 274,489   $ 7 $ 375,873   $ 2,287 $ (103,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)     348,013        
Issuance of common stock upon exercise of stock options 63     63      
Issuance of common stock upon settlement of restricted stock units (in shares)     1,830,986        
Stock-based compensation - restricted stock   $ 9,348     $ 9,348    
Shares withheld related to net share settlement (in shares)     (15,939)        
Shares withheld related to net share settlement (116)     (116)      
Issuance of common stock for settlement of contingent consideration compensation (earn-out) (in shares)     384,756        
Issuance of common stock for settlement of contingent consideration compensation (earn-out) 1,785     1,785      
Other comprehensive income (loss) (557)         (557)  
Net income (loss) (22,135)           (22,135)
Ending Balance (in shares) at Sep. 30, 2023     74,208,433        
Ending Balance at Sep. 30, 2023 262,877   $ 7 386,953   1,730 (125,813)
Beginning Balance (in shares) at Jun. 30, 2023     73,169,003        
Beginning Balance at Jun. 30, 2023 260,764   $ 7 383,629   3,230 (126,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)     47,228        
Issuance of common stock upon exercise of stock options 9     9      
Issuance of common stock upon settlement of restricted stock units (in shares)     996,062        
Stock-based compensation - restricted stock   3,330     3,330    
Shares withheld related to net share settlement (in shares)     (3,860)        
Shares withheld related to net share settlement (15)     (15)      
Other comprehensive income (loss) (1,500)         (1,500)  
Net income (loss) 289           289
Ending Balance (in shares) at Sep. 30, 2023     74,208,433        
Ending Balance at Sep. 30, 2023 262,877   $ 7 386,953   1,730 (125,813)
Beginning Balance (in shares) at Dec. 31, 2023     75,131,425        
Beginning Balance at Dec. 31, 2023 234,300   $ 7 390,083   3,964 (159,754)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)     690,463        
Issuance of common stock upon exercise of stock options 124     124      
Issuance of common stock upon settlement of restricted stock units (in shares)     2,167,937        
Stock-based compensation - restricted stock   15,367     15,367    
Shares withheld related to net share settlement (in shares)     (604,698)        
Shares withheld related to net share settlement (1,765)     (1,765)      
Issuance of common stock for settlement of contingent consideration (earn-out) (in shares)     1,008,998        
Issuance of common stock for settlement of contingent consideration compensation (earn-out) 3,022     3,022      
Repurchase and retirement of common stock (in shares)     (80,102)        
Repurchase and retirement of common stock (244)     (407)     163
Other comprehensive income (loss) 209         209  
Net income (loss) (17,514)           (17,514)
Ending Balance (in shares) at Sep. 30, 2024     78,314,023        
Ending Balance at Sep. 30, 2024 233,499   $ 7 406,424   4,173 (177,105)
Beginning Balance (in shares) at Jun. 30, 2024     77,934,085        
Beginning Balance at Jun. 30, 2024 229,386   $ 7 401,753   2,777 (175,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)     59,000        
Issuance of common stock upon exercise of stock options 11     11      
Issuance of common stock upon settlement of restricted stock units (in shares)     581,305        
Stock-based compensation - restricted stock   $ 5,402     $ 5,402    
Shares withheld related to net share settlement (in shares)     (260,367)        
Shares withheld related to net share settlement (742)     (742)      
Other comprehensive income (loss) 1,396         1,396  
Net income (loss) (1,954)           (1,954)
Ending Balance (in shares) at Sep. 30, 2024     78,314,023        
Ending Balance at Sep. 30, 2024 $ 233,499   $ 7 $ 406,424   $ 4,173 $ (177,105)